Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PORT ANGELES, Wash., Jan. 26, 2023 (GLOBE NEWSWIRE) -- First Northwest Bancorp (Nasdaq: FNWB) Q4 2022 Net IncomeQ4 2022 Diluted Earnings Per ShareYTD Loan GrowthQ4 2022 Net Interest MarginBook Value...
-
View Smart Windows to be installed at a new mixed use development in Manhattan’s Inwood neighborhood, increasing natural light and access to views in apartment units and improving the health and...
-
HONITON, UNITED KINGDOM, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The team detailed the GDCC tokenomics to allow users to understand and appreciate its value. In addition, the listing will allow the GDCC...
-
LONDON and SALT LAKE CITY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the launch of PRIME-CKD*, a consortium of industry, academic and clinical research...
-
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSX – V: HPM) (the “Company” or “Halcones”) is pleased to announce that Mr. Ian Parkinson will join the Company as Chief...
-
VANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Almadex Minerals Ltd. ("Almadex" or the "Company") (TSX-V: “DEX) is pleased to announce completion of its updated mineral resource...
-
Leveraging RevID’s Automated Charge Reconciliation for Improved Financial Performance Atlanta, GA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading...
-
NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the commercial launch of BRIUMVI™ (ublituximab-xiiy), for the treatment of relapsing forms of...
-
Newark, New Castle, USA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global neuromodulation devices market is expected to clock US$ 12.54...
-
Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment NAC-GED-0507 is a Phase III-ready New Chemical Entity (NCE),...